Yield Theory

Congressional trades by ticker

GMED congressional trades

Globus Medical, Inc. Class A Common Stock appears in 6 verified House Clerk rows from Gilbert Cisneros, Josh Gottheimer, and Lisa McClain across the 2025–2026 periodic reports. The table keeps disclosed owners and amount ranges; it is not a live GMED portfolio.
Verified rows
6
Filers
3
Purchases
3
Latest trade
2026-08-19

Verified GMED House disclosures

Parsed from official House Clerk periodic transaction reports. This snapshot contains 3 purchases and 3 sales. Reported owners: Self, Spouse, Joint. Transaction dates run from 2025-04-09 to 2026-08-19.

PoliticianTrade dateAssetTypeOwnerAmountFiling
Gilbert CisnerosGlobus Medical, Inc. Class A Common StockPurchaseSelf$15,001 - $50,000#20035390
Filed 2026-09-10
Gilbert CisnerosGlobus Medical, Inc. Class A Common StockPurchaseSelf$1,001 - $15,000#20034285
Filed 2026-04-07
Lisa McClainGlobus Medical, Inc. Class A Common StockSaleSpouse$1,001 - $15,000#20030891
Filed 2025-08-13
Lisa McClainGlobus Medical, Inc. Class A Common StockSaleSpouse$1,001 - $15,000#20030891
Filed 2025-08-13
Lisa McClainGlobus Medical, Inc. Class A Common StockPurchaseSpouse$1,001 - $15,000#20030891
Filed 2025-08-13
Josh GottheimerGlobus Medical, Inc. Class A Common StockSaleJoint$1,001 - $15,000#20030338
Filed 2025-05-14

A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.

The filing is free

Keep the GMED range and owner as filed. Membership adds the investment view around the money, not a list to copy.

Get this month’s call for $15

GMED congressional trades — FAQ

Who in Congress traded GMED?

House Clerk periodic reports for 2025 and 2026 contain 6 verified GMED rows from 3 members: Gilbert Cisneros, Josh Gottheimer, and Lisa McClain. Image-only filings are excluded, and this is not a live brokerage statement.

Does this page show current GMED holdings?

No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.

Why are GMED amounts shown as ranges?

House periodic transaction reports use statutory value bands such as $15,001 - $50,000; $1,001 - $15,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.

How complete is GMED congressional-trade coverage?

This snapshot covers every machine-readable House periodic transaction report for 2025 and 2026 (142 members). Image-only filings and Senate eFD filings are not included, so missing rows are not proof that no other lawmaker traded GMED.

Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk periodic report snapshot generated 2026-09-20. It is not a complete lifetime portfolio, a performance track record, or investment advice.

A disclosure is not a thesis.

This page shows who reported GMED and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included